Large language models for infectious diseases require evidence generation and regulation

Area of Science:

• Healthcare technology
• Infectious diseases
• Artificial intelligence

Background:

• Large language models (LLMs) present significant opportunities within the healthcare sector.
• The Australian infectious diseases (ID) context requires extensive information synthesis.
• Integrating LLMs in ID necessitates careful consideration of existing healthcare frameworks.

Purpose of the Study:

• To explore the potential of large language models (LLMs) in the Australian infectious diseases (ID) domain.
• To identify strategies for maximizing the benefits of LLMs in ID.
• To outline methods for mitigating the risks associated with LLM implementation in ID.

Main Methods:

• The study reviews the application of LLMs in healthcare, focusing on the ID context.
• It emphasizes the importance of evidence-based medicine principles and robust clinical trials.
• It discusses the role of regulatory frameworks and guideline development.
• The integration of AI architectures, specifically retrieval-augmented generation, is examined.

Main Results:

• LLMs have the potential to significantly aid in information gathering and synthesis in Australian infectious diseases.
• Implementing LLMs requires adherence to evidence-based medicine, rigorous trials, and clear regulatory guidelines.
• Proactive strategies, including AI architectures like retrieval-augmented generation, are crucial for risk mitigation.

Conclusions:

• The effective use of LLMs in Australian infectious diseases (ID) hinges on a multi-faceted approach.
• Combining LLMs with evidence-based practices, strong regulatory oversight, and advanced AI techniques is essential.
• This approach will optimize benefits while managing the inherent risks of LLM deployment in ID.